Health In Tech, Inc. Financials
This page shows Health In Tech, Inc. (HIT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Health In Tech, Inc.'s revenue grew a modest 1.8% year-over-year to $19.5M. This slow but positive growth earns a score of 34/100.
Health In Tech, Inc. carries a low D/E ratio of 0.20, meaning only $0.20 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 5.06, Health In Tech, Inc. holds $5.06 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
Health In Tech, Inc. generates a 5.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 20/100. This is down from 65.0% the prior year.
Health In Tech, Inc. passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Health In Tech, Inc. generates $3.25 in operating cash flow ($2.2M OCF vs $670K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Health In Tech, Inc. generated $19.5M in revenue in fiscal year 2024. This represents an increase of 1.8% from the prior year.
Health In Tech, Inc. reported $670K in net income in fiscal year 2024. This represents a decrease of 83.1% from the prior year.
Health In Tech, Inc. held $7.8M in cash against $0 in long-term debt as of fiscal year 2024.
Health In Tech, Inc.'s gross margin was 79.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 8.8 percentage points from the prior year.
Health In Tech, Inc.'s net profit margin was 3.4% in fiscal year 2024, showing the share of revenue converted to profit. This is down 17.2 percentage points from the prior year.
Health In Tech, Inc.'s ROE was 5.1% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 59.9 percentage points from the prior year.
Health In Tech, Inc. invested $2.8M in research and development in fiscal year 2024. This represents an increase of 40.4% from the prior year.
HIT Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.5M-8.8% | $9.3M+16.2% | $8.0M+63.4% | $4.9M+10.0% | $4.5M-10.9% | $5.0M-2.4% | $5.1M | N/A |
| Cost of Revenue | $3.3M+11.4% | $3.0M+12.9% | $2.7M+140.2% | $1.1M+13.0% | $980K+0.5% | $975K-1.5% | $990K | N/A |
| Gross Profit | $5.1M-18.5% | $6.3M+17.8% | $5.4M+41.0% | $3.8M+9.1% | $3.5M-13.6% | $4.0M-2.6% | $4.1M | N/A |
| R&D Expenses | $236K-59.5% | $583K+8.3% | $538K-15.1% | $634K-11.8% | $718K+2.4% | $702K-7.7% | $760K | N/A |
| SG&A Expenses | $3.5M-8.6% | $3.8M+16.3% | $3.2M+14.0% | $2.8M+57.0% | $1.8M-0.2% | $1.8M-9.1% | $2.0M | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | $0-100.0% | $165K0.0% | $165K0.0% | $165K | N/A |
| Income Tax | $148K-26.9% | $203K+9.0% | $186K+456.3% | $33K+9.0% | $31K-51.6% | $63K-30.6% | $91K | N/A |
| Net Income | $452K-28.3% | $631K+26.5% | $499K+445.9% | -$144K-138.3% | $376K+11.3% | $338K+236.2% | $101K | N/A |
| EPS (Diluted) | $0.010.0% | $0.010.0% | $0.01 | N/A | $0.010.0% | $0.01 | N/A | N/A |
HIT Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.8M+2.6% | $22.2M+4.0% | $21.3M+35.3% | $15.8M | N/A | N/A | N/A | $11.5M |
| Current Assets | $15.0M+1.3% | $14.9M-4.6% | $15.6M+44.4% | $10.8M | N/A | N/A | N/A | $6.9M |
| Cash & Equivalents | $8.0M-1.4% | $8.1M+7.4% | $7.6M-3.5% | $7.8M+349.2% | $1.7M-19.2% | $2.2M+59.1% | $1.4M-43.7% | $2.4M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $869K-32.2% | $1.3M-39.3% | $2.1M+28.1% | $1.6M | N/A | N/A | N/A | $2.2M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $5.6M-2.7% | $5.8M-19.7% | $7.2M+175.8% | $2.6M | N/A | N/A | N/A | $5.4M |
| Current Liabilities | $5.2M-2.8% | $5.4M-20.2% | $6.8M+216.9% | $2.1M | N/A | N/A | N/A | $4.8M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $17.2M+4.5% | $16.4M+16.0% | $14.2M+7.5% | $13.2M+90.6% | $6.9M+5.8% | $6.5M+5.5% | $6.2M+1.6% | $6.1M |
| Retained Earnings | $5.5M+8.9% | $5.1M+14.2% | $4.4M+12.7% | $3.9M | N/A | N/A | N/A | $3.3M |
HIT Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $674K-54.5% | $1.5M+180.9% | $527K+199.3% | -$531K-125.0% | $2.1M+67.5% | $1.3M+286.2% | -$680K | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$745K+18.1% | -$910K-29.3% | -$703K-29.8% | -$542K-705.8% | -$67K+28.4% | -$94K+29.6% | -$133K | N/A |
| Financing Cash Flow | -$44K-429.5% | -$8K+91.6% | -$98K-101.4% | $7.2M+390.5% | -$2.5M-569.5% | -$369K-51.7% | -$243K | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
HIT Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.6%-7.2pp | 67.8%+0.9pp | 66.8%-10.6pp | 77.4%-0.6pp | 78.0%-2.5pp | 80.5%-0.2pp | 80.7% | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 5.3%-1.4pp | 6.8%+0.5pp | 6.2%+9.2pp | -2.9%-11.4pp | 8.4%+1.7pp | 6.8%+4.8pp | 2.0% | N/A |
| Return on Equity | 2.6%-1.2pp | 3.8%+0.3pp | 3.5% | N/A | 5.4%+0.3pp | 5.2%+3.6pp | 1.6% | N/A |
| Return on Assets | 2.0%-0.9pp | 2.8%+0.5pp | 2.3%+3.3pp | -0.9% | N/A | N/A | N/A | N/A |
| Current Ratio | 2.87+0.1 | 2.76+0.5 | 2.31-2.8 | 5.06 | N/A | N/A | N/A | 1.43 |
| Debt-to-Equity | 0.33-0.0 | 0.35-0.2 | 0.51+0.3 | 0.20 | N/A | N/A | N/A | 0.89 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Health In Tech, Inc.'s annual revenue?
Health In Tech, Inc. (HIT) reported $19.5M in total revenue for fiscal year 2024. This represents a 1.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Health In Tech, Inc.'s revenue growing?
Health In Tech, Inc. (HIT) revenue grew by 1.8% year-over-year, from $19.2M to $19.5M in fiscal year 2024.
Is Health In Tech, Inc. profitable?
Yes, Health In Tech, Inc. (HIT) reported a net income of $670K in fiscal year 2024, with a net profit margin of 3.4%.
What is Health In Tech, Inc.'s gross margin?
Health In Tech, Inc. (HIT) had a gross margin of 79.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Health In Tech, Inc.'s net profit margin?
Health In Tech, Inc. (HIT) had a net profit margin of 3.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Health In Tech, Inc.'s return on equity (ROE)?
Health In Tech, Inc. (HIT) has a return on equity of 5.1% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Health In Tech, Inc.'s operating cash flow?
Health In Tech, Inc. (HIT) generated $2.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Health In Tech, Inc.'s total assets?
Health In Tech, Inc. (HIT) had $15.8M in total assets as of fiscal year 2024, including both current and long-term assets.
How much does Health In Tech, Inc. spend on research and development?
Health In Tech, Inc. (HIT) invested $2.8M in research and development during fiscal year 2024.
What is Health In Tech, Inc.'s current ratio?
Health In Tech, Inc. (HIT) had a current ratio of 5.06 as of fiscal year 2024, which is generally considered healthy.
What is Health In Tech, Inc.'s debt-to-equity ratio?
Health In Tech, Inc. (HIT) had a debt-to-equity ratio of 0.20 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Health In Tech, Inc.'s return on assets (ROA)?
Health In Tech, Inc. (HIT) had a return on assets of 4.3% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Health In Tech, Inc.'s Piotroski F-Score?
Health In Tech, Inc. (HIT) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Health In Tech, Inc.'s earnings high quality?
Health In Tech, Inc. (HIT) has an earnings quality ratio of 3.25x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Health In Tech, Inc.?
Health In Tech, Inc. (HIT) scores 63 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.